Tien Liang Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 13, 2019 at 01:44 am IST
Share
Tien Liang BioTech Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 99.326 million compared to TWD 140.557 million a year ago. Operating loss was TWD 17.825 million compared to TWD 14.009 million a year ago. Net loss was TWD 16.010 million compared to TWD 18.040 million a year ago. Basic loss per share was TWD 0.35 compared to TWD 0.39 a year ago. For the half year, sales was TWD 210.365 million compared to TWD 265.637 million a year ago. Operating loss was TWD 36.920 million compared to TWD 23.209 million a year ago. Net loss was TWD 34.320 million compared to TWD 27.582 million a year ago. Basic loss per share was TWD 0.75 compared to TWD 0.6 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.